The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Clozapine, Diabetes Mellitus, Weight Gain, and Lipid Abnormalities: A Five-Year Naturalistic Study
Abstract
OBJECTIVE: The goal of this 5-year naturalistic study of patients treated with clozapine was to examine the incidence of treatment-emergent diabetes mellitus in relation to other factors, including weight gain, lipid abnormalities, age, clozapine dose, and treatment with valproate. METHOD: Data on age, gender, race, diagnosis, family history of diabetes, and age at clozapine initiation were collected from medical records of 82 outpatients with schizophrenia or schizoaffective disorder. Clozapine dose, data on use of valproate, and laboratory test results were recorded at 6-month intervals. RESULTS: The mean age at the time of clozapine initiation of the 82 patients was 36.4 years; 26.8% of the patients were women, and 91.5% were Caucasian. The mean baseline weight was 175.5 lb, and the mean body mass index was 26.9 kg/m(2). Thirty patients (36.6%) were diagnosed with diabetes during the 5-year follow-up. Weight gain, use of valproate, and total daily dose of clozapine were not significant risk factors for developing diabetes mellitus. Patients experienced significant weight gain that continued until approximately month 46 from initiation of clozapine. There was a nonsignificant increase in total serum cholesterol and a significant increase in serum triglycerides level. CONCLUSIONS: The results support the hypotheses that patients treated with clozapine experience significant weight gain and lipid abnormalities and appear to be at increased risk for developing diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.
National Diabetes Data Group (1979) · Diabetes · doi:10.2337/diab.28.12.1039 · Cited by 4,909
Clozapine for the Treatment-Resistant Schizophrenic: A Double-blind Comparison With Chlorpromazine
Kane, J. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800330013001 · Cited by 4,156
Excess mortality of mental disorder
Harris, C., & Barraclough, B. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.173.1.11 · Cited by 1,881
Pi-Sunyer, F. X. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-7_part_2-199310011-00006 · Cited by 1,371
Polycystic Ovaries and Hyperandrogenism in Women Taking Valproate for Epilepsy
Isojarvi, J., Laatikainen, T. J., Pakarinen, A. J., Juntunen, K., & Myllyla, V. V. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311043291904 · Cited by 688
Novel antipsychotics and new onset diabetes
Wirshing, D. A., Spellberg, B. J., Erhart, S. M., Marder, S. R., & Wirshing, W. C. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00100-0 · Cited by 407
Short-Term Medical Benefits and Adverse Effects of Weight Loss
Pi-Sunyer, F. X. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-7_part_2-199310011-00019 · Cited by 392
Diabetes mellitus in schizophrenic patients
Mukherjee, S., Decina, P., Bocola, V., Saraceni, F., & Scapicchio, P. (1996) · Comprehensive Psychiatry · doi:10.1016/s0010-440x(96)90054-1 · Cited by 368
Valproate, lamotrigine, and insulin‐mediated risks in women with epilepsy
Isojärvi, J. I. T., Rättyä, J., Myllylä, V. V., Knip, M., Koivunen, R., Pakarinen, A. J., Tekay, A., & Tapanainen, J. S. (1998) · Annals of Neurology · doi:10.1002/ana.410430406 · Cited by 342
Meltzer, H. Y., Burnett, S., Bastani, B., & Ramirez, L. F. (1990) · Psychiatric Services · doi:10.1176/ps.41.8.892 · Cited by 338
Kelly West Lecture 1991 Challenges in Diabetes Epidemiology—From West to the Rest
Zimmet, P. Z. (1992) · Diabetes Care · doi:10.2337/diacare.15.2.232 · Cited by 333
Mortality in Current and Former Users of Clozapine
Walker, A. M., Lanza, L. L., Arellano, F., & Rothman, K. J. (1997) · Epidemiology · doi:10.1097/00001648-199710000-00010 · Cited by 328
Clozapine-induced weight gain: prevalence and clinical relevance
(1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.1.68 · Cited by 248
Drug-Induced Disorders of Glucose Tolerance
Pandit, M. K., Burke, J., Gustafson, A. B., Minocha, A., & Peiris, A. N. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-7-199304010-00008 · Cited by 239
Mortality in Current and Former Users of Clozapine
Walker, A. M., Lanza, L. L., Arellano, F., & Rothman, K. J. (1997) · Epidemiology · doi:10.1097/00001648-199711000-00014 · Cited by 239
Honigfeld, G., Arellano, F. M., Sethi, J., Bianchini, A., & Schein, J. R. (1998) · PubMed · Cited by 216
Hagg, S., Joelsson, L., Mjorndal, T., Spigset, O., Oja, G., & Dahlqvist, R. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0604 · Cited by 211
Clozapine and Associated Diabetes Mellitus
Popli, A. P., Konicki, P. E., Jurjus, G. J., Fuller, M. A., & Jaskiw, G. E. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n0304 · Cited by 185
Umbricht, D., Pollack, S. Z., & Kane, J. (1994) · PubMed · Cited by 179
Differential effect of clozapine on weight: a controlled study
Bustillo, J., Buchanan, R. W., Irish, D., & Breier, A. F. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.6.817 · Cited by 157
Clinical Efficacy of Clozapine in Treatment-Refractory Schizophrenia: An Overview
Kane, J. M. (1992) · The British Journal of Psychiatry · doi:10.1192/s0007125000296918 · Cited by 147
Phenothiazines and Diabetes in Hospitalized Women
Thonnard‐Neumann, E. (1968) · American Journal of Psychiatry · doi:10.1176/ajp.124.7.978 · Cited by 145
Drexel, H., Amann, F. W., Beran, J., Rentsch, K., CANDINAS, R., Muntwyler, J., Luethy, A., Gasser, T., & Folláth, F. (1994) · Circulation · doi:10.1161/01.cir.90.5.2230 · Cited by 134
Habitual Dietary Intake and Glucose Tolerance in Euglycaemic Men: The Zutphen Study
Feskens, E. J. M., & Kromhout, D. (1990) · International Journal of Epidemiology · doi:10.1093/ije/19.4.953 · Cited by 132
Suicide in schizophrenia: risk factors and clozapine treatment.
Meltzer, H. Y. (1998) · PubMed · Cited by 91
Serum triglyceride levels in patients treated with clozapine
Ghaeli, P., & Dufresne, R. L. (1996) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/53.17.2079 · Cited by 85
Ketoacidosis as a side‐effect of clozapine: a case report
Kostakolu, A. E., Yazici, M. K., Erbas, T. A., & Guvener, N. D. (1996) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1996.tb10635.x · Cited by 78
Effect of duration of low-dose oral contraceptive administration on carbohydrate metabolism
Wynn, V. (1982) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(16)32481-4 · Cited by 74
DRUG-PRODUCED OBESITY. EXPERIENCES WITH CHLORPROMAZINE, PERPHENAZINE AND CLOPENTHIXOL.
Amdisen, A. (1964) · PubMed · Cited by 66
Clozapine-Induced Diabetic Ketoacidosis
Smith, H., Kenney‐Herbert, J., & Knowles, L. (1999) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/0004867900027 · Cited by 50
Persistent tardive dyskinesia and neuroleptic effects on glucose tolerance
Mukherjee, S., Roth, S. D., Sandyk, R., & Schnur, D. B. (1989) · Psychiatry Research · doi:10.1016/0165-1781(89)90183-2 · Cited by 39
Triphasic Randomized Clinical Trial: Comparison of effects on carbohydrate metabolism
Bowes, W., Katta, L. R., Droegemueller, W., & Bright, T. G. (1989) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(89)90704-7 · Cited by 22
Research works printed but not linked: 10
- Honigfeld G: The Clozapine National Registry system: forty years of risk management. J Clin Psychiatry Monograph 1996; 14:29–32
- Lamberti JS, Bellnier T, Schwarzkopf SB: Weight gain among schizophrenic patients treated with clozapine. Am J Psychiatry 1992; 149:689–690 · doi:10.1176/ajp.149.5.689
- Cohen S, Chiles J, MacNaughton A: Weight gain associated with clozapine. Am J Psychiatry 1990; 147:503–504 · doi:10.1176/ajp.147.4.503
- Koval MS, Rames LJ, Christie S: Diabetic ketoacidosis associated with clozapine treatment (letter). Am J Psychiatry 1994; 151:1520–1521 · doi:10.1176/ajp.151.10.1520b
- Peterson GA, Byrd SL: Diabetic ketoacidosis from clozapine and lithium cotreatment (letter). Am J Psychiatry 1996; 153:737–738 · doi:10.1176/ajp.153.5.737b
- Kamran A, Doraiswamy PM, Jane JL, Hammett EB, Dunn L: Severe hyperglycemia associated with high doses of clozapine (letter). Am J Psychiatry 1994; 151:1395 · doi:10.1176/ajp.151.9.1395a
- Keskiner A, el-Toumi A, Bousquet T: Psychotropic drugs, diabetes and chronic mental patients. Psychosomatics 1973; 14:176–181 · doi:10.1016/s0033-3182(73)71353-0
- Schwartz L, Munoz R: Blood sugar levels in patients treated with chlorpromazine. Am J Psychiatry 1968; 125:253–255 · doi:10.1176/ajp.125.2.253
- Proakis AG, Mennear JH, Miya TS, Borowitz JL: Phenothiazine-induced hyperglycemia: relation to CNS and adrenal effects. Proc Soc Exp Biol Med 1971; 137:1385–1388 · doi:10.3181/00379727-137-35794
- Tollefson G, Lesar T: Nonketotic hyperglycemia associated with loxapine and amoxapine: case report. J Clin Psychiatry 1983; 44:347–348
Cited by
Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline
Apovian, C. M., Aronne, L. J., Bessesen, D. H., McDonnell, M. E., Murad, M. H., Pagotto, U., Ryan, D. H., & Still, C. D. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3415 · Cited by 1,347
Second-Generation (Atypical) Antipsychotics and Metabolic Effects: A Comprehensive Literature Review
Newcomer, J. W. (2005) · CNS Drugs · doi:10.2165/00023210-200519001-00001 · Cited by 1,340
Schizophrenia and increased risks of cardiovascular disease
Hennekens, C. H., Hennekens, A. R., Hollar, D., & Casey, D. E. (2005) · American Heart Journal · doi:10.1016/j.ahj.2005.02.007 · Cited by 1,070
Clinical Practice Recommendations
Fowler, M. J. (2011) · Clinical Diabetes · doi:10.2337/diaclin.29.4.163 · Cited by 995
Antipsychotic Drugs: Prolonged QTc Interval, Torsade de Pointes, and Sudden Death
Glassman, A. H., & Bigger, J. T. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.11.1774 · Cited by 822
Metadata
- Authors
- Henderson, D. C., Cagliero, E., Gray, C., Nasrallah, R. A., Hayden, D. L., Schoenfeld, D. A., & Goff, D. C.
- Venue
- American Journal of Psychiatry
- Published
- 2000-06-01
- Volume
- 157
- Issue
- 6
- Pages
- 975-981
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2089671853
- Cited by
- 701
- References
- 34
- FWCI
- 35.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.